Five common cancers in Iran
- PMID: 20187669
Five common cancers in Iran
Abstract
Iran as a developing nation is in epidemiological transition from communicable to non-communicable diseases. Although, cancer is the third cause of death in Iran, it;s mortality are on the rise during recent decades. This mini-review was carried out to provide a general viewpoint on common cancers incidence in Iran and to explain incidental differences that may help us to establish early detection programs and investigate population risk factors. A detailed PubMed, Scopus and Google scholar search were made from 2000 to 2009. The basic inclusion criteria were all relevant studies focused on cancer epidemiological data from Iran. Overall age-standard incidence rate per 100 000 population according to primary site is 110.43 in males and 98.23 in females. The five most common cancers (except skin cancer) are stomach, esophagus, colon-rectum, bladder and leukemia in males, and in females are breast, esophagus, stomach, colon-rectum and cervix uteri. The incidence rates of gastrointestinal cancers are high in Iran (it is one of the known areas with a high incidence of GI cancers). Breast cancer mainly affects Iranian women about a decade earlier than Western countries and younger cases are affected by an increasing rate of colorectal cancer in Iran, near the Western rates.
Similar articles
-
Demographic survey of four thousand patients with 10 common cancers in North Eastern Iran over the past three decades.Asian Pac J Cancer Prev. 2014;15(23):10193-8. doi: 10.7314/apjcp.2014.15.23.10193. Asian Pac J Cancer Prev. 2014. PMID: 25556447
-
Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance.Cancer Detect Prev. 2006;30(1):14-9. doi: 10.1016/j.cdp.2005.11.002. Epub 2006 Feb 21. Cancer Detect Prev. 2006. PMID: 16495018
-
Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.PLoS One. 2016 May 24;11(5):e0155669. doi: 10.1371/journal.pone.0155669. eCollection 2016. PLoS One. 2016. PMID: 27219458 Free PMC article.
-
Epidemiology of cancer in the United States.Prim Care. 1992 Sep;19(3):419-41. Prim Care. 1992. PMID: 1410056 Review.
-
Singapore cancer trends in the last decade.Singapore Med J. 2012 Jan;53(1):3-9; quiz 10. Singapore Med J. 2012. PMID: 22252175 Review.
Cited by
-
Degarelix for the treatment of advanced prostate cancer compared with GnRh-Agonists: a systematic review and meta-analysis.Med J Islam Repub Iran. 2016 Jan 9;30:317. eCollection 2016. Med J Islam Repub Iran. 2016. PMID: 27390687 Free PMC article.
-
Incidence trends of colorectal cancer in Iran during 2000-2009: A population-based study.Med J Islam Repub Iran. 2016 Jun 5;30:382. eCollection 2016. Med J Islam Repub Iran. 2016. PMID: 27493926 Free PMC article.
-
SMAD4 mutations identified in Iranian patients with colorectal cancer and polyp.Gastroenterol Hepatol Bed Bench. 2021 Fall;14(Suppl1):S32-S40. Gastroenterol Hepatol Bed Bench. 2021. PMID: 35154600 Free PMC article.
-
Incidence and Mortality of Various Cancers in Iran and Compare to Other Countries: A Review Article.Iran J Public Health. 2018 Mar;47(3):309-316. Iran J Public Health. 2018. PMID: 29845017 Free PMC article. Review.
-
Survival Analysis of Breast Cancer Patients after Surgery with an Intermediate Event: Application of Illness-Death Model.Iran J Public Health. 2015 Dec;44(12):1677-84. Iran J Public Health. 2015. PMID: 26811819 Free PMC article.